Internal Medicine · Pacific Palisades, CA
NPI
1528254133
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
881 Alma Real Dr, Suite 103
Pacific Palisades, CA, 90272
Phone (310) 459-4333
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
4,389 services
Medicare patients, 2024
553
Average age 76
Drug cost, 2024
$956K
8,935 prescriptions
Company payments, 2025
$20K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Damon B Raskin was code 99214 (office e&m - established), 1,442 times for 516 patients. In total Damon B Raskin billed 4,389 services in 46 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,442 | 516 | $92.79 | $134K |
| 36415 Venipuncture Blood Collection | Office | 814 | 464 | $8.65 | $7,041 |
| 81002 Clinical Chemistry | Office | 354 | 303 | $3.41 | $1,207 |
| 93000 Electrocardiogram | Office | 336 | 292 | $10.69 | $3,591 |
| 94010 Pulmonary Function Testing | Office | 258 | 258 | $20.65 | $5,327 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 239 | 239 | $127.65 | $31K |
| G0008 Administration of influenza virus vaccine | Office | 141 | 140 | $35.02 | $4,938 |
| 96372 Injection Administration | Office | 118 | 33 | $11.03 | $1,302 |
| 99215 Office E&M - Established | Office | 91 | 79 | $135.65 | $12K |
| 90662 Vaccine Product | Office | 77 | 77 | $81.82 | $6,300 |
| 90656 Vaccine Product | Office | 62 | 61 | $21.90 | $1,358 |
| 77080 Standard X-ray | Office | 62 | 62 | $40.20 | $2,492 |
| 99443 Telephone Services | Office | 60 | 50 | $78.43 | $4,706 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 49 | 22 | $26.81 | $1,314 |
| 69210 Other Organ Systems | Office | 28 | 26 | $36.24 | $1,015 |
By year: 2022 $249K for 4,640 services; 2023 $258K for 4,510 services; 2024 $232K for 4,389 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 814 | 464 | $8.65 | $7,041 |
| 81002 Clinical Chemistry | 354 | 303 | $3.41 | $1,207 |
Medicare prescription drug claims, 2024
In 2024, the drug Damon B Raskin prescribed most often to Medicare patients was Levothyroxine Sodium, with 415 prescriptions and refills. In total Damon B Raskin wrote 8,935 Medicare prescriptions that cost $956K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 415 | 869 | 93 | $4,875 |
| Atorvastatin Calcium Generic | 397 | 942 | 102 | $3,807 |
| Rosuvastatin Calcium Generic | 337 | 794 | 95 | $5,349 |
| Amlodipine Besylate Generic | 308 | 666 | 68 | $2,283 |
| Zolpidem Tartrate Generic | 242 | 265 | 62 | $1,334 |
| Metformin Hcl Generic | 200 | 442 | 49 | $1,360 |
| Synthroid Levothyroxine Sodium | 191 | 414 | 37 | $13K |
| Trazodone Hcl Generic | 188 | 255 | 50 | $1,420 |
| Bupropion Xl Bupropion Hcl | 178 | 300 | 40 | $4,804 |
| Lorazepam Generic | 174 | 174 | 45 | $608 |
| Escitalopram Oxalate Generic | 162 | 346 | 44 | $2,144 |
| Alprazolam Generic | 135 | 137 | 47 | $428 |
| Gabapentin Generic | 132 | 165 | 40 | $1,759 |
| Eszopiclone Generic | 123 | 131 | 16 | $1,902 |
| Dayvigo Lemborexant | 107 | 111 | 18 | $36K |
Brand drugs: 1,435 claims; generic drugs: 7,477 claims; opioid claims: 175.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Damon B Raskin $20K ($20K in general payments such as food, travel and fees) from 31 companies. The largest payer was Alkermes, Inc. with $8,962.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 17 | $8,962 |
| Eli Lilly and Company LLY | 3 | $7,533 |
| Abbvie Inc. ABBV | 42 | $802 |
| Pfizer Inc. PFE | 13 | $325 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $295 |
| Indivior Inc. INDV | 9 | $260 |
| Lundbeck LLC | 12 | $241 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $236 |
| Harmony Biosciences LLC HRMY | 3 | $165 |
| Novo Nordisk Inc NVO | 8 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.